Square Pharmaceuticals (DHA:SQURPHARMA) Accounts Payable & Accrued Expense : BDT3,018 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Square Pharmaceuticals Accounts Payable & Accrued Expense?

Square Pharmaceuticals's quarterly accounts payable & accrued expense increased from Sep. 2023 (BDT2,616 Mil) to Dec. 2023 (BDT14,618 Mil) but then declined from Dec. 2023 (BDT14,618 Mil) to Mar. 2024 (BDT3,018 Mil).

Square Pharmaceuticals's annual accounts payable & accrued expense declined from Jun. 2021 (BDT2,996 Mil) to Jun. 2022 (BDT2,230 Mil) but then increased from Jun. 2022 (BDT2,230 Mil) to Jun. 2023 (BDT2,315 Mil).

Square Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Square Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Square Pharmaceuticals Accounts Payable & Accrued Expense Chart

Square Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,928.39

2,253.28

2,995.51

2,229.80

2,315.24

Square Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															3,284.66	2,315.24	2,615.61	14,617.72	3,018.32

Square Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Square Pharmaceuticals (DHA:SQURPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Square Pharmaceuticals PLC (DHA:SQURPHARMA) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

Square Centre, 48, Mohakhali Commercial Area, Dhaka, BGD, 1212

Website

http://www.squarepharma.com.bd

Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals products, Basic chemical products, and animal health products. It manufactures drugs like paracetamol, clotrimazole, antiallergic, Nitroglycerin, xylometazoline HCl, erythromycin, and various other drugs. The company operates in Bangladesh and sells its products locally and internationally. The company operates in one segment, which is the business of developing, manufacturing, and marketing drugs.

Square Pharmaceuticals (DHA:SQURPHARMA) Headlines

No Headlines